The Pharma Letter: Huge potential for oral insulin candidate, says Oramed CEO Nadav Kidron
Despite an inexorable rise in the global population of type 2 diabetics, linked to changing lifestyle… Read the full article on www.thepharmaletter.com
Lake Forest Patch: OC Oral Insulin Clinical Trial Could Be Next Step For Treatment
This Tustin based Oral Insulin clinical trial in Orange County will test treatment for those with type 2 diabetes over the next 90 days. Read the full article on patch.com
New Atlas: Oral insulin proving successful in human clinical trials
For decades researchers have worked to find a way to orally administer insulin effectively to patients with diabetes. Now this game-changing treatment is one step closer to reality, with pharmaceutical company Oramed embarking on a final Phase 2b human clinical trial to prove the efficacy [...]
B2B News Network: Inside The Mind Of . . . Nadav Kidron
Nadav Kidron serves as Chief Executive Officer of Oramed Pharmaceuticals, which he co-founded in 2006. Their orally-taken insulin is game-changing technology that could revolutionize the way millions people with diabetes administer their medication. Read the full article on b2bnn.com
WKYC: Nadav Kidron-Oramed Pharmaceuticals is Changing The Lives of Diabetic Patients
Millions of diabetics inject insulin daily, and millions more are on the path to injections. But Oramed Pharmaceuticals aims to change that reality, with an insulin pill. Currently in clinical trials, the oral insulin capsule could radically change how we treat diabetes, and dramatically change [...]
Forbes: AI And Radar: The Future Of Noninvasive Blood Sugar Monitoring?
The “wish list”, or holy grail for diabetics who prick their finger several times a day to measure their blood sugar usually involves two things: a way to check their blood sugar without painful finger pricks, and taking a pill instead of an insulin shot. [...]
Oramed on CNN: Insulin pill instead of shot: How close are we for diabetes patients?
(CNN)Daily insulin shots for the management of Type 1 and Type 2 diabetes could become a thing of the past, and insulin pills could someday be another option for diabetes patients. to read the rest of the article press here
Bloomberg: Oramed Plans Secondary Listing in Tel Aviv Soon, CEO Nadav Kidron Says
Oramed Pharmaceuticals Inc. plans a secondary listing in Tel Aviv “in the next few weeks” to take advantage of an increasing number of Israeli investors seeking new opportunities amid new measures to invigorate the stock market, CEO Nadav Kidron told Bloomberg.
Oramed CEO Nadav Kidron on CNBC: Oral insulin to be a gamechanger
Oral insulin to be a game changer: Oramed CEO Nadav Kidron tells CNBC On Squawk Box Asia, Kidron talks about the company's latest offering
BioTuesdays: Oramed hopes to start Phase 3 oral insulin trial next year
Josh Hexter, Oramed’s COO, spoke with BioTuesdays.com about the conclusion of the Phase IIb study, and about what's next for Oramed: Oramed hopes to start Phase 3 oral insulin trial next year